This invention relates to a prophylactic and therapeutic composition for inhibiting rotavirus infection, and more particularly to a method of preventing and treating diseases or conditions associated with, or requiring, rotavirus infection, using defatted human milk globules (HMFGs), milk macromolecular fraction, curd, whey, the human milk mucin complex or a polypeptide having the rotavirus-bindin